Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST
The FDA’s Drug Supply Chain Security Act (DSCSA) deadline requiring all pharmaceutical manufacturers and suppliers to serialize individual units and provide electronic track and trace for every product that travels through the supply chain was November 27, 2023. Join this discussion led by Bill Fletcher, Senior Director of Traceability and Electronic Client Communications at Knipper Health, to help you consider the critical topics for compliance and potential options for resolution.
Register Free: https://www.pharmaceuticalcommerce.com/pc/serialization-program
Event Overview:
The FDA’s Drug Supply Chain Security Act (DSCSA) deadline requiring all pharmaceutical manufacturers and suppliers to serialize individual units and provide electronic track and trace for every product that travels through the supply chain was November 27, 2023. Full implementation of these requirements can be complicated, costly, time consuming and confusing. This discussion led by Bill Fletcher, Senior Director of Traceability and Electronic Client Communications at Knipper Health, will help you consider the following topics including various options for resolution.
Key Learning Objectives:
Who Should Attend:
Speaker:
Bill Fletcher
Senior Director, Traceability and Electronic Client Communications
Knipper 3PL
Bill Fletcher is an experienced executive with a 41-plus year history in the life sciences industry, with leadership roles in pharmaceutical and biotech packaging and labeling, research and development, warehousing, distribution, and medical devices.
For 18 years before joining Knipper Health, Fletcher was managing director of Pharma Logic Solutions, LLC, a consulting company that specializes in compliance with global traceability and serialization regulations. He has assisted over 65 manufacturers, wholesalers and 3PL and distribution providers to implement serialization systems, packaging, labeling and related procedures—including several of the world’s largest drug or distribution providers—with both internal or contracted manufacturing, packaging and distribution.
For decades, Fletcher has spoken to audiences of hundreds during industry events around the world and across the United States. In 2013, he was asked to share his experience by speaking in the U.S. Capitol to congressional staff developing the Federal Drug Quality and Security Act (DQSA) of 2013, and more specifically, its Title II, the Drug Supply Chain Security Act (DSCSA), to improve the integrity of the U.S. drug supply chain and foster greater patient safety.
Register Free:
https://www.pharmaceuticalcommerce.com/pc/serialization-program